Streetbeat News

Products Services

REGN

The FDA has approved Regeneron Pharmaceuticals' drug, Veopoz, for the treatment of CHAPLE disease in adults and children over one year old. Veopoz is the first and only treatment specifically for CHAPLE, an ultra-rare and life-threatening hereditary immune disease. The drug will be sold in the U.S. at a list price of $34,615.38 per single-use vial. Following the news, REGN shares rose by 1.45%.

Portfolio Pulse from Vandana Singh

August 21, 2023 | 2:18 pm

QRTEA

HSN, a Qurate Retail company, and Fanatics, a global digital sports platform, have announced a partnership to enhance the shopping experience for sports fans. The collaboration will expand HSN's sports assortment across its digital platforms, offering a significant assortment of league and team merchandise. The partnership kicked off with hundreds of MLB products launched on HSN.com from Fanatics' inventory, with NFL and college merchandise to follow soon. Fanatics will also extend its hot market and championship collections as part of the deal.

Portfolio Pulse from Happy Mohamed

August 21, 2023 | 2:03 pm

GELYF

Lotus Cars, a British automaker, is set to deliver its first fully electric hypercar, the Evija, later this year. The car, which was first unveiled in 2019, is the first new car launched by Lotus after partnering with Chinese automaker Geely Automobile Holdings Ltd (OTC:GELYF) in 2017. The Evija, priced at roughly $1.63 million, is one of the most expensive EVs in the world. Lotus plans to produce no more than 130 examples of the two-seater car.

Portfolio Pulse from Anan Ashraf

August 21, 2023 | 2:02 pm

AAPL

Apple Inc. (NASDAQ:AAPL) is rumored to be launching color-matched braided USB-C cables with the iPhone 15, according to Apple prototype device collector 'Kosutami'. This move could address complaints about the durability of iPhone charging cables. The iPhone 15 series is expected to launch on September 12, with features such as a titanium design, Action Button, a new periscope camera on the top-tier iPhone 15 Pro Max, faster 35W charging, and a USB-C port.

Portfolio Pulse from Rounak Jain

August 21, 2023 | 1:53 pm

F

GM

HYMTF

RIVN

TSLA

WKSP

Electric pickup trucks are gaining traction, with Rivian's R1T already on the road and Tesla's Cybertruck expected by year-end. Worksport Ltd's SOLIS and COR products are designed to enhance the power of these vehicles. SOLIS is a solar-powered tonneau cover that can charge EV pickups, while COR is a portable battery system. Ford Motor and General Motors are also mentioned as players in the EV pickup market, but Ford is facing setbacks and is expected to lose $1.5 billion more than anticipated this year in its EV segment.

Portfolio Pulse from Upwallstreet

August 21, 2023 | 1:52 pm

APPN

Appian (NASDAQ:APPN) has announced the immediate availability of the latest version of the Appian AI-Powered Process Platform, featuring Appian AI Copilot, an AI assistant that boosts developer productivity. The AI Copilot uses generative AI to convert PDF and other structured forms into digital interfaces. The latest release also includes a more secure and scalable data fabric, a user-friendly AI Skill Designer experience, and a more unified Appian RPA. Axiom Space, a developer of next-generation spacesuits, uses Appian's data fabric and process automation to support its spacesuit for a future mission to the Moon.

Portfolio Pulse from Happy Mohamed

August 21, 2023 | 1:31 pm

EH

EHang's Unmanned Aircraft Cloud System has been approved by the Civil Aviation Administration of China. This approval positions the EH216-S for post-TC commercial operations.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 1:24 pm

ANEB

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) has received positive feedback from the FDA for its drug ANEB-001, used for acute cannabinoid intoxication (ACI). The FDA suggests that a single well-controlled study of ANEB-001 could potentially support a new drug application. Anebulo has also completed dosing in an open-label part C extension of its phase 2 clinical trial to evaluate the safety and efficacy of ANEB-001. Full safety, pharmacokinetic, and pharmacodynamic data from the study are expected in Q4 2023.

Portfolio Pulse from Vuk Zdinjak

August 21, 2023 | 1:23 pm

AAPL

Apple's stock experienced an 11% drop after hitting record highs in July, with significant drops in August. However, the stock showed signs of improvement by the end of the week, closing up 0.28%. The upcoming release of the iPhone 15 series is anticipated to boost investor confidence and potentially propel the stock to new heights. Despite recent fluctuations, Apple's stock has seen a 33% growth this year.

Portfolio Pulse from Zaheer Anwari

August 21, 2023 | 1:13 pm

SABR

Sabre and Scandinavian Airlines have expanded their distribution agreement to include New Distribution Capability (NDC) content for Sabre-connected agents worldwide. This allows Sabre-connected agencies to retain access to Scandinavian Airlines' fares and offers through Sabre Travel Market Place, and enables Scandinavian Airlines to distribute future NDC content.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 1:11 pm